Dr Reddy's Laboratories ROA 2006-2018 | RDY

Current and historical return on assets (ROA) values for Dr Reddy's Laboratories (RDY) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Dr Reddy's Laboratories ROA for the three months ending September 30, 2018 was 7.34%.
Dr Reddy's Laboratories ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $0.24B $3.23B 6.97%
2018-06-30 $0.21B $3.37B 6.07%
2018-03-31 $0.15B $3.47B 4.38%
2017-12-31 $0.16B $3.54B 4.64%
2017-09-30 $0.18B $3.40B 5.21%
2017-06-30 $0.18B $3.38B 5.24%
2017-03-31 $0.19B $3.39B 5.75%
2016-12-31 $0.14B $3.35B 4.32%
2016-09-30 $0.16B $3.31B 5.00%
2016-06-30 $0.22B $2.90B 7.27%
2016-03-31 $0.30B $3.13B 9.64%
2015-12-31 $0.38B $3.14B 12.14%
2015-09-30 $0.38B $3.09B 12.45%
2015-06-30 $0.37B $3.16B 12.10%
2015-03-31 $0.36B $3.13B 12.18%
2014-12-31 $0.36B $2.93B 12.38%
2014-09-30 $0.37B $2.85B 12.93%
2014-06-30 $0.38B $2.89B 13.87%
2014-03-31 $0.35B $2.84B 13.17%
2013-12-31 $0.38B $2.72B 14.41%
2013-09-30 $0.35B $2.58B 13.46%
2013-06-30 $0.31B $2.54B 12.30%
2013-03-31 $0.31B $2.61B 12.58%
2012-12-31 $0.27B $2.53B 11.39%
2012-09-30 $0.30B $2.47B 12.85%
2012-06-30 $0.29B $2.28B 12.61%
2012-03-31 $0.29B $2.35B 12.68%
2011-12-31 $0.29B $2.31B 13.31%
2011-09-30 $0.26B $2.20B 12.28%
2011-06-30 $0.26B $2.20B 12.96%
2011-03-31 $0.25B $2.13B 12.96%
2010-12-31 $0.21B $1.87B 11.47%
2010-09-30 $0.03B $1.79B 1.97%
2010-06-30 $0.02B $1.77B 0.88%
2010-03-31 $0.02B $1.79B 1.23%
2009-12-31 $-0.21B $1.57B -12.45%
2009-09-30 $-0.06B $1.71B -3.15%
2009-06-30 $-0.08B $1.76B -4.03%
2009-03-31 $-0.10B $1.65B -4.87%
2008-12-31 $0.12B $1.98B 5.93%
2008-09-30 $0.06B $2.06B 2.98%
2008-06-30 $0.10B $2.12B 4.97%
2008-03-31 $0.12B $2.14B 5.78%
2007-12-31 $0.17B $2.00B 8.69%
2007-09-30 $0.33B $2.04B 16.75%
2007-06-30 $0.36B $1.93B 18.50%
2007-03-31 $0.34B $1.99B 18.29%
2006-12-31 $0.22B $1.97B 12.44%
2006-09-30 $0.09B $1.81B 6.51%
2006-06-30 $0.02B $1.69B 1.96%
2006-03-31 $0.00B $1.55B 0.11%
2005-12-31 $0.03B $0.73B 4.24%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $5.645B $2.204B
Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally, with focus on India, US, Europe and Russia. They conduct research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $54.860B 9.42
Teva Pharmaceutical Industries (TEVA) Israel $23.927B 7.33
Mylan (MYL) United Kingdom $18.439B 7.59
Bausch Health Cos (BHC) Canada $9.314B 6.74
Mallinckrodt Public Limited Company (MNK) United Kingdom $2.589B 4.32
Supernus Pharmaceuticals (SUPN) United States $2.357B 22.33
Amphastar Pharmaceuticals (AMPH) United States $0.978B 106.05
Akorn (AKRX) United States $0.853B 0.00
Homology Medicines (FIXX) United States $0.748B 0.00
Assembly Biosciences (ASMB) United States $0.570B 0.00
CymaBay Therapeutics (CBAY) United States $0.536B 0.00
Corium (CORI) United States $0.458B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.451B 0.00
Voyager Therapeutics (VYGR) United States $0.384B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.315B 0.00
Teligent (TLGT) United States $0.170B 0.00
Sol-Gel Technologies (SLGL) Israel $0.135B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.095B 0.00
Aevi Genomic Medicine (GNMX) United States $0.076B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.053B 0.00
Evoke Pharma (EVOK) United States $0.046B 0.00
Acasti Pharma (ACST) Canada $0.042B 0.00
Agile Therapeutics (AGRX) United States $0.032B 0.00
China Pharma Holdings (CPHI) China $0.016B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.008B 0.00